Literature DB >> 36258770

Identification of antigens recognized by salivary IgA using microbial protein microarrays.

Koji Hamuro1, Hiroshi Saito1, Takao Saito1, Noriyuki Kohda1.   

Abstract

Secretory IgA plays an important role in the mucosal immune system for protection against pathogens. However, the antigens recognized by these antibodies have only been partially studied. We comprehensively investigated the antigens bound by salivary IgA in healthy adults using microbial protein microarrays. This confirmed that saliva contained IgA antibodies that bind to a variety of pathogenic microorganisms, including spike proteins of severe acute respiratory syndrome coronavirus 2, severe acute respiratory syndrome coronavirus, Middle East respiratory syndrome coronavirus, and other human coronavirus species. Also, many subtypes and strains of influenza virus were bound, regardless of the seasonal or vaccine strains. Salivary IgA also bound many serogroups and serovars of Escherichia coli and Salmonella. Taken together, these findings suggest that salivary IgA, which exhibits broad reactivity, is likely an essential element of the mucosal immune system at the forefront of defense against infection. ©2022 BMFH Press.

Entities:  

Keywords:  IgA; antigen; saliva; virus bacteria

Year:  2022        PMID: 36258770      PMCID: PMC9533030          DOI: 10.12938/bmfh.2022-014

Source DB:  PubMed          Journal:  Biosci Microbiota Food Health        ISSN: 2186-3342


  54 in total

1.  Stressful life events of dental students and salivary immunoglobulin A.

Authors:  V Ng; D Koh; B Mok; L P Lim; Y Yang; S E Chia
Journal:  Int J Immunopathol Pharmacol       Date:  2004 May-Aug       Impact factor: 3.219

Review 2.  The evolution of seasonal influenza viruses.

Authors:  Velislava N Petrova; Colin A Russell
Journal:  Nat Rev Microbiol       Date:  2017-10-30       Impact factor: 60.633

Review 3.  Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.

Authors:  Tadaki Suzuki; Akira Ainai; Hideki Hasegawa
Journal:  Vaccine       Date:  2017-08-07       Impact factor: 3.641

4.  IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration.

Authors:  Yoshihiko Terauchi; Kaori Sano; Akira Ainai; Shinji Saito; Yuki Taga; Kiyoko Ogawa-Goto; Shin-Ichi Tamura; Takato Odagiri; Masato Tashiro; Mikiya Fujieda; Tadaki Suzuki; Hideki Hasegawa
Journal:  Hum Vaccin Immunother       Date:  2018-04-09       Impact factor: 3.452

5.  Salivary IgA as a Predictor of Upper Respiratory Tract Infections and Relationship to Training Load in Elite Rugby Union Players.

Authors:  Caoimhe Tiernan; Mark Lyons; Tom Comyns; Alan M Nevill; Giles Warrington
Journal:  J Strength Cond Res       Date:  2020-03       Impact factor: 3.775

Review 6.  The evolution and future of influenza pandemic preparedness.

Authors:  Walter N Harrington; Christina M Kackos; Richard J Webby
Journal:  Exp Mol Med       Date:  2021-05-06       Impact factor: 8.718

7.  Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.

Authors:  Junpei Ohtsuka; Masaki Imai; Masayuki Fukumura; Mitsuyo Maeda; Asami Eguchi; Ryoichi Ono; Tadashi Maemura; Mutsumi Ito; Seiya Yamayoshi; Yosky Kataoka; Yoshihiro Kawaoka; Tetsuya Nosaka
Journal:  iScience       Date:  2021-11-17

8.  Detection of cross-reactive immunoglobulin A against the severe acute respiratory syndrome-coronavirus-2 spike 1 subunit in saliva.

Authors:  Keiichi Tsukinoki; Tatsuo Yamamoto; Keisuke Handa; Mariko Iwamiya; Juri Saruta; Satoshi Ino; Takashi Sakurai
Journal:  PLoS One       Date:  2021-11-23       Impact factor: 3.240

Review 9.  The impact of human vaccines on bacterial antimicrobial resistance. A review.

Authors:  Kathrin U Jansen; William C Gruber; Raphael Simon; James Wassil; Annaliesa S Anderson
Journal:  Environ Chem Lett       Date:  2021-09-29       Impact factor: 13.615

Review 10.  The mucosal immune system of the upper respiratory tract and recent progress in mucosal vaccines.

Authors:  Yuichi Kurono
Journal:  Auris Nasus Larynx       Date:  2021-07-23       Impact factor: 1.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.